GCCPL is an Indian-based pharmaceutical and nutraceutical company with a global presence. GCCPL provides customized, technology-driven healthcare solutions to meet the evolving needs of today’s market ...

Final Written Decisions in Pfizer’s IPR2021-00925 and IPR2021-00926 finding all challenged claims of uniQure’s U.S. Patent No. 9,982,248 (“the ’248 patent”) unpatentable (CAFC 23-1404 and 23-1405), ...

President Donald Trump’s pick to be U.S. surgeon general has said the nation’s medical and food systems are corrupted by ...

US drug companies are increasingly licensing experimental medicines invented by Chinese firms. The recent deals could be ...

President Donald Trump’s pick to be the next U.S. surgeon general has repeatedly said the nation’s medical, health and food ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

We speak with the Co-Chair of The Left Group in the European Parliament, French MEP Manon Aubry. A noted advocate for ...

Vepdegestrant showed a benefit for patients with ER-positive, HER2-negative, ESR1-mutated breast cancer who had previously received endocrine-based therapy.

A new partnership between Hartford HealthCare and Pfizer is taking aim at migraines in the workplace. The innovative program ...

Patent claims reciting compounds where at least one group of a compound genus is defined by its function are common. For ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...